Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Songge Jiangniaosuan
- Development stage
- Unknown
- Lead developer
- Zhejiang Chinese Medical University
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Songge Jiangniaosuan is a Traditional Chinese Medicine (TCM) preparation developed by Zhejiang Chinese Medical University, primarily indicated for the treatment of hyperuricemia and gout. The formulation is centered on extracts from *Pinus massoniana* (pine) and *Pueraria lobata* (kudzu root). Its therapeutic effect is attributed to its ability to lower serum uric acid levels by inhibiting xanthine dehydrogenase (xanthine oxidase), the enzyme responsible for uric acid production, and potentially enhancing renal uric acid excretion through the modulation of transporters such as solute carrier family 22 member 12 (URAT1). It is typically administered orally in granule form and has undergone clinical evaluation in China to assess its efficacy in reducing urate levels and preventing gout flares.
- Brand names
- Songge Jiangniaosuan
- Other names
- Songge Jiangniaosuan GranulesSongge Jiangniaosuan formulaSongge Jiangniaosuan Tang松葛降尿酸颗粒
02
Targets
XO (Xanthine Oxidoreductase)URAT1 (Uric Acid Transporter 1)
Beyond the preview
Go deeper on Songge Jiangniaosuan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Songge Jiangniaosuan.